Figure 2. Expression of PD-L1 on immune cells and tumor cells in pleural and ascites fluids of MPM patients.

Data of eleven different patient samples are shown: five ascites (·) and six pleural (▲) fluids. Percentages of marker-positive cells were determined using the overton subtraction tool in the FlowJo software. The bar represents the median value within all samples.